EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 14 September 2023

News

SOTEU 2023: Reconciling policy and practice
13 September 2023

Our hope now is that we can work with all parties to make the legislation enhance rather than hinder European competitiveness... Read more

Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body...
12 September 2023

How can we ensure that oncology-relevant endpoints reflect the value of innovation for patients, clinicians, payers... Read more

EFPIA working with Ukraine on EU accession and medicines and vaccines regulatory alignment...
12 September 2023

Representatives from the European Federation of Pharmaceutical Industries and Associations (EFPIA) today met in Brussels... Read more

Did you miss our latest event? Watch the recording!

Unlocking the potential of new oncology treatments.

A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints... Read more

Events

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis...
26 September 2023 (Online)

Moving towards a new Alzheimer’s disease detection and diagnosis pathway Read more

Are medicines affordable for health systems?
29 September 2023 (Bad Hofgastein, Austria)

The myths, the facts, and the way forward Read more

33rd Alzheimer Europe Conference
16 October 2023 (Helsinki, Finland, & virtual)

New opportunities in dementia care, policy and research Read more

EFGCP Better Medicines for Children Conference 2023
17 October 2023 (Amsterdam)

Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration Read more

Publications

Improving the understanding, acceptance and use of oncology–relevant endpoints in HTA body / payer decision-making.

Read EFPIA's latest White Paper.

What we are reading

Lars Fruergaard Jørgensen, the Novo Nordisk boss who dethroned Europe’s biggest company
On 08 September 2023 (Financial Times)

Danish pharma chief is leading the expansion of blockbuster obesity drug that propelled shares to record high.

New AI tool makes it possible to predict weight loss after bariatric surgery
On 30 August 2023 (University College Dublin)

IHI public-private partnerships contribute to addressing public health challenges. Have a look at the Sophia project... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu